{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:21:27Z","timestamp":1738387287783,"version":"3.35.0"},"reference-count":24,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":14183,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1979,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Monoamine oxidase (MAO) levels in plasma, platelets, lymphocytes and granulocytes have been compared in schizophrenics and controls using three substrates. No significant difference was found between MAO levels in controls and the schizophrenic group as a whole, but platelets and lymphocytes of the latter (tyramine or benzylamine substrate) showed greater variation and in some cases higher values than controls, irrespective of treatment. Schizophrenics who experienced auditory hallucinations had significantly lower MAO levels in lymphocytes and platelets than those who did not.<\/jats:p>","DOI":"10.1192\/bjp.134.4.360","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T22:35:43Z","timestamp":1218580543000},"page":"360-365","source":"Crossref","is-referenced-by-count":17,"title":["Monoamine Oxidase (Mao) of Platelets, Plasma, Lymphocytes and Granulocytes in Schizophrenia"],"prefix":"10.1192","volume":"134","author":[{"given":"Peter A.","family":"Bond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Cundall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian R. H.","family":"Falloon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"volume-title":"Clinical Psychopathology.","year":"1959","author":"Schneider","key":"S0007125000058451_ref18"},{"key":"S0007125000058451_ref13","doi-asserted-by":"publisher","DOI":"10.1017\/S1120962300024112"},{"key":"S0007125000058451_ref8","doi-asserted-by":"publisher","DOI":"10.1038\/238225a0"},{"key":"S0007125000058451_ref7","article-title":"Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients","volume":"7","author":"Meltzer","year":"1974","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"S0007125000058451_ref17","article-title":"Elevated platelet monoamine oxidase activity in schizophrenia\u2014related depressive disorders","volume":"135","author":"Schildkraut","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000058451_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(77)90039-0"},{"key":"S0007125000058451_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(68)90163-9"},{"key":"S0007125000058451_ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760160093019"},{"key":"S0007125000058451_ref19","doi-asserted-by":"publisher","DOI":"10.1038\/253659b0"},{"key":"S0007125000058451_ref16","article-title":"Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients","volume":"133","author":"Schildkraut","year":"1976","journal-title":"American Journal of Psychiatry"},{"volume-title":"The Measurement and Classification of Psychiatric Symptoms.","year":"1974","author":"Wing","key":"S0007125000058451_ref21"},{"key":"S0007125000058451_ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770110105011"},{"key":"S0007125000058451_ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.130.2.151"},{"key":"S0007125000058451_ref22","article-title":"Preparation of human platelets","volume":"39","author":"Youdim","year":"1976","journal-title":"CIBA Foundation Symposium"},{"key":"S0007125000058451_ref15","doi-asserted-by":"crossref","DOI":"10.1016\/S0031-6997(25)06919-4","article-title":"Multiple forms of monoamine oxidase functional significance","volume":"24","author":"Sandler","year":"1972","journal-title":"Pharmacological Reviews"},{"key":"S0007125000058451_ref4","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-0039.1974.tb00252.x","article-title":"Separation of blood leucocytes, granulocytes and lymphocytes","volume":"4","author":"Boyum","year":"1974","journal-title":"Tissue Antigens"},{"key":"S0007125000058451_ref11","first-page":"59","volume-title":"Neuropsychopharmacology of Monoamines and their Regulatory Enzymes.","author":"Nies","year":"1974"},{"key":"S0007125000058451_ref2","article-title":"Platelet monoamine oxidase in chronic schizophrenic patients","volume":"135","author":"Berger","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000058451_ref6","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.1974.131.12.1392","article-title":"Blood platelet monoamine oxidase activity in psychiatric patients","volume":"131","author":"Friedman","year":"1974","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000058451_ref20","first-page":"393","article-title":"Assay of monoamine oxidase","volume":"39","author":"Tipton","year":"1976","journal-title":"CIBA Foundation Symposium"},{"key":"S0007125000058451_ref23","article-title":"Human platelet monoamine oxidase activity in iron-deficiency anaemia","volume":"48","author":"Youdim","year":"1975","journal-title":"Clinical Science and Molecular Medicine"},{"key":"S0007125000058451_ref24","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.18.1.98"},{"key":"S0007125000058451_ref12","article-title":"Platelet monoamine oxidase in schizophrenia","volume":"33","author":"Owen","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"S0007125000058451_ref5","article-title":"An investigation of platelet monoamine oxidase activity","volume":"39","author":"Brockington","year":"1976","journal-title":"Schizophrenia and Schizoaffective Psychosis."}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000058451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:25:28Z","timestamp":1738326328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000058451\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1979,4]]}},"alternative-id":["S0007125000058451"],"URL":"https:\/\/doi.org\/10.1192\/bjp.134.4.360","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"type":"print","value":"0007-1250"},{"type":"electronic","value":"1472-1465"}],"subject":[],"published":{"date-parts":[[1979,4]]}}}